Abstract
A 24-year-old woman was diagnosed with juvenile myoclonic epilepsy (JME) since age 14 and managed by her pediatric neurologist. She has been successfully treated and remained seizure free on valproic acid 500 mg twice daily for several years. She has never been tried on any other seizure medications. She has a full-time job as a real estate agent and drives clients around the city. She reports no side effects on valproic acid. She has been transferred to your care as an adult neurologist. She got married 2 years ago and is planning to become pregnant and start a family in the next year or two. How would you counsel her regarding the risks for teratogenicity of her seizure medication and what treatment changes would you make, if any?.
| Original language | English |
|---|---|
| Title of host publication | Controversies in Caring for Women with Epilepsy |
| Subtitle of host publication | Sorting Through the Evidence |
| Publisher | Springer International Publishing |
| Pages | 73-79 |
| Number of pages | 7 |
| ISBN (Electronic) | 9783319291703 |
| ISBN (Print) | 9783319291680 |
| DOIs | |
| State | Published - 1 Jan 2016 |
| Externally published | Yes |
Keywords
- Autism
- Congenital malformation
- Juvenile myoclonic epilepsy
- Lamotrigine
- Levetiracetam
- Neurodevelopment
- Pre-pregnancy counselling
- Pregnancy
- Teratogenesis
- Valproate
- Valproic acid
Fingerprint
Dive into the research topics of 'Valproic acid and pregnancy: Not tried other medications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver